Cellectis (CLLS)
(Delayed Data from NSDQ)
$2.05 USD
+0.15 (7.89%)
Updated Jul 3, 2024 12:57 PM ET
After-Market: $2.04 -0.01 (-0.49%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.33 |
EPS Last Quarter | -0.15 |
Last EPS Surprise | NA |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.54 |
Next Year | -0.51 |
EPS (TTM) | -1.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.00M | 5.00M | 19.00M | 60.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 6.00M | 5.00M | 19.00M | 60.00M |
Low Estimate | 6.00M | 5.00M | 19.00M | 60.00M |
Year ago Sales | 2.00M | 1.64M | 9.19M | 19.00M |
Year over Year Growth Est. | 200.00% | 204.88% | 106.66% | 215.79% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.33 | -0.20 | -0.54 | -0.51 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.33 | -0.20 | -0.54 | -0.51 |
Low Estimate | -0.33 | -0.20 | -0.54 | -0.51 |
Year ago EPS | -0.14 | -0.31 | -2.05 | -0.54 |
Year over Year Growth Est. | -135.71% | 35.48% | 73.66% | 5.56% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.33 | -0.20 | -0.54 | -0.51 |
7 Days Ago | -0.33 | -0.20 | -0.54 | -0.51 |
30 Days Ago | NA | NA | -1.06 | -0.89 |
60 Days Ago | NA | NA | -1.06 | -0.89 |
90 Days Ago | NA | NA | -1.06 | -0.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.33 | -0.20 | -0.54 | -0.51 |
Zacks Consensus Estimate | -0.33 | -0.20 | -0.54 | -0.51 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.15 | -0.64 | -0.31 | -0.14 | NA |
Estimate | NA | NA | -0.36 | -0.38 | NA |
Difference | NA | NA | 0.05 | 0.24 | 0.15 |
Surprise | NA | NA | 13.89% | 63.16% | 38.53% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more